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INTRODUCTION
The gut barrier consists of a single layer of intestinal epithelial cells
(IECs) and the tight junctions between them. It allows absorption
of nutrients from the intestinal lumen into the circulation, while
preventing the entry of injurious microorganisms, toxins and
antigens. In the small intestine, IECs are generated in the crypt,
migrate up the villus and are shed at the villus tip (Leblond and
Stevens, 1948). In mice, which exhibit whole IEC shedding similar
to that which occurs in humans (Bullen et al., 2006), ~1400 IECs
are estimated to be shed in this way from a single villus tip per day
(Potten and Loeffler, 1990). The small intestine therefore has one
of the highest cell turnover rates in the body, with an estimated
1011 and 2×108 cells being shed per day from the small intestine of
humans and mice, respectively (Potten and Loeffler, 1990). During
the process of physiological cell shedding, the highly coordinated
process of tight junction rearrangement that is required to allow
the detachment and release of IECs from the epithelium maintains
the gut barrier (Madara, 1990).
In various inflammatory conditions, however, the loss of IECs
from the villus exceeds the rate of epithelial generation in the crypt.
This process, which we have termed ‘pathological IEC shedding’
remains poorly understood. Such pathological IEC shedding might
represent the earliest intestinal injury in a variety of intestinal
diseases and is likely to have important consequences, potentially
resulting in gap formation in the epithelium, permeability defects
and villus shortening (villus atrophy). Indeed, increased numbers
of shedding IECs with corresponding focal permeability defects and
epithelial gaps have been observed in inflammatory bowel disease
(IBD), including both Crohn’s disease (CD) and ulcerative colitis
(UC) (Kiesslich et al., 2012; Liu et al., 2011). It has also been shown
that individuals at high risk of developing IBD exhibit increased
gastrointestinal permeability (Hollander et al., 1986). Similarly, IL-
10-deficient mice exhibit increased small intestinal permeability
prior to the development of spontaneous colitis. In this animal
model, colitis severity can be markedly reduced by administering
a specific pharmacological inhibitor that reduces small intestinal
permeability by preventing the opening of tight junctions, and is
prevented completely by rearing animals in germ-free conditions
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SUMMARY
The gut barrier, composed of a single layer of intestinal epithelial cells (IECs) held together by tight junctions, prevents the entrance of harmful
microorganisms, antigens and toxins from the gut lumen into the blood. Small intestinal homeostasis is normally maintained by the rate of shedding
of senescent enterocytes from the villus tip exactly matching the rate of generation of new cells in the crypt. However, in various localized and
systemic inflammatory conditions, intestinal homeostasis can be disturbed as a result of increased IEC shedding. Such pathological IEC shedding
can cause transient gaps to develop in the epithelial barrier and result in increased intestinal permeability. Although pathological IEC shedding has
been implicated in the pathogenesis of conditions such as inflammatory bowel disease, our understanding of the underlying mechanisms remains
limited. We have therefore developed a murine model to study this phenomenon, because IEC shedding in this species is morphologically analogous
to humans. IEC shedding was induced by systemic lipopolysaccharide (LPS) administration in wild-type C57BL/6 mice, and in mice deficient in TNF-
receptor 1 (Tnfr1−/−), Tnfr2 (Tnfr2−/−), nuclear factor kappa B1 (Nfκb1−/−) or Nfĸb2 (Nfĸb2−/−). Apoptosis and cell shedding was quantified using
immunohistochemistry for active caspase-3, and gut-to-circulation permeability was assessed by measuring plasma fluorescence following
fluorescein-isothiocyanate–dextran gavage. LPS, at doses ≥0.125 mg/kg body weight, induced rapid villus IEC apoptosis, with peak cell shedding
occurring at 1.5 hours after treatment. This coincided with significant villus shortening, fluid exudation into the gut lumen and diarrhea. A significant
increase in gut-to-circulation permeability was observed at 5 hours. TNFR1 was essential for LPS-induced IEC apoptosis and shedding, and the fate
of the IECs was also dependent on NFκB, with signaling via NFκB1 favoring cell survival and via NFκB2 favoring apoptosis. This model will enable
investigation of the importance and regulation of pathological IEC apoptosis and cell shedding in various diseases.
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(Arrieta et al., 2009). This suggests a crucial link between small
intestinal permeability, luminal antigens and the development of
chronic colitis.
Although recombinant tumor necrosis factor (TNF) has been
previously shown to induce pathological intestinal villus epithelial
cell shedding in mice (Kiesslich et al., 2007), the exogenous
administration of this cytokine in isolation does not reflect the
complexity of the mammalian inflammatory response that is
present in most disease states. In addition, the concentrations of
exogenous TNF required to induce IEC shedding are higher than
found in vivo, making such experiments expensive and possibly
yielding artefactual results. We have also found TNF to be an
inconsistent stimulus of IEC shedding. We therefore sought to find
a simple, inexpensive, rapid, reproducible and pathologically
relevant stimulus to investigate the process of IEC shedding in detail
in an animal model.
Lipopolysaccharide (LPS) is an integral component of Gram-
negative bacteria and is a potent activator of the innate immune
system. It represents a pathogen-associated molecular pattern
(PAMP) recognized by Toll-like receptor 4 (TLR4) (Beutler et al.,
2001), which initiates a systemic inflammatory response, with
nuclear factor kappa B (NFκB) signaling pathways playing a central
role in cell responses downstream of both TLR (Chow et al., 1999)
and subsequent cytokine receptor ligation (Jacque et al., 2005). We
therefore hypothesized that the mammalian systemic inflammatory
response was capable of causing IEC apoptosis and shedding at the
villus tip when triggered by LPS, and that this occurred prior to
the onset of apoptosis in the crypt.
We have therefore examined in detail the earliest phase of LPS-
induced murine gut injury. We demonstrate that intraperitoneally
administered LPS is a simple, rapid and consistent stimulus of villus
IEC apoptosis and shedding in the murine small intestine and that
this occurs several hours prior to the onset of crypt apoptosis. This
early response coincides with fluid effusion into the small intestinal
lumen and diarrhea. We have subsequently characterized the dose
response and the kinetics of this highly dynamic phenomenon.
Using knockout mouse models, we have found that TNFR1-
mediated signaling is essential for these events, with an NFκB2-
dominant response favoring apoptosis. These data provide
interesting insights into the control of IEC homeostasis in
inflammatory disease, because the NFκB2 pathway has not
previously been linked to IEC apoptosis and shedding.
RESULTS
Systemic LPS caused clinical signs and gross pathological changes
from 1.5 hours, with fluid exudation into the intestinal lumen
To establish the time-dependent intestinal effects of LPS, we
administered 10 mg phenol-extracted LPS (PE-LPS)/kg body weight
by intraperitoneal (i.p.) injection to adult female wild-type (WT)
mice, and euthanized them after 1, 1.5, 2, 3, 4 and 6 hours. Diarrhea
was observed from 1.5-2 hours. At necropsy, there was serosal pallor
of the small intestine (Fig. 1A), which exhibited distension with
watery yellow fluid. These observations showed that LPS caused
acute fluid exudation into the gut lumen with acute onset diarrhea.
LPS caused small intestinal villus IEC loss and shedding from
1.5 hours
We performed histopathological examination of hematoxylin and
eosin (H&E)-stained sections to characterize intestinal injury. At
1.5 hours (Fig. 1A) there was marked villus shortening, clubbing
and blunting. IECs at the villus tip exhibited variable separation
and detachment from neighboring cells, often with a teardrop
morphology and an apically positioned nucleus (consistent with
cell shedding and apoptosis). Large numbers of shed IECs were
present within the lumen. Comparable injury was not observed in
the stomach, colon or other organs investigated (supplementary
material Fig. S1). These observations suggest that LPS causes rapid
and specific small intestinal villus epithelial injury, and that peak
shedding correlates with the onset of clinical diarrhea.
LPS caused rapid villus shortening with IEC loss in the duodenum,
jejunum and ileum
Because villus shortening is commonly utilized as a measure of
small intestinal damage, we measured villus heights after LPS
TRANSLATIONAL IMPACT
Clinical issue
Epithelial cell loss and defects in the epithelial barrier are common early
events in the pathogenesis of acute intestinal or diarrheal diseases as well as
chronic intestinal inflammatory disorders, such as Crohn’s disease and
ulcerative colitis. Increased intestinal epithelial cell (IEC) shedding, which is
potentially associated with increased gut permeability, is thought to be a key
contributor to these initial injuries. However, the molecular events underlying
IEC shedding and disruption of intestinal barrier integrity during inflammatory
disease states remain poorly understood. A robust animal model would greatly
facilitate in-depth investigation of these processes. Mice exhibit a
morphologically analogous form of small intestinal villus epithelial cell
shedding to that observed in humans and have the potential to allow
important mechanistic insights because of the availability of established
transgenic and conditional mutant models.
Results
Utilizing the inflammatory response induced by systemic administration of
lipopolysaccharide (LPS) in mice, the authors developed a new model for the
investigation of IEC shedding. A threshold dose of ≥0.125 mg LPS/kg body
weight delivered by intraperitoneal injection induced rapid and dynamic villus
IEC apoptosis and shedding, which peaked at 1.5 hours post-administration.
This coincided with significant villus shortening, fluid exudation into the gut
and the onset of diarrhea. Activation of caspase-3 occurred concomitantly
with IEC shedding in virtually all affected cells, suggesting that apoptosis is
triggered within the epithelium prior to cells being shed. By examining the
responses to LPS in transgenic mice, the authors showed that TNFR1 is
essential for the induction of apoptosis and shedding. Furthermore, the fate of
IECs is dependent on NFκB signaling, with signaling by NFκB1 favoring cell
survival and signaling via NFκB2 favoring apoptosis. 
Implications and future directions
Systemic LPS administration in mice provides an effective and reliable trigger
of pathological IEC shedding that parallels that observed in human intestinal
diseases. The authors’ detailed characterization of affected mice confirms that
villus epithelial apoptosis and cell shedding occurs with acute fluid exudation
into the gut, leading to diarrhea. Furthermore, they provide evidence that
TNFR1 and NFκB2-dominant signaling pathways are important in IEC
apoptosis and shedding. By conducting an in-depth investigation of the
kinetics, dose response and signaling mechanisms underlying these processes,
they have established a novel and robust model that will facilitate further
investigation of epithelial gap formation and barrier dysfunction in the
inflamed intestinal epithelium. Further studies using this model are likely to
provide insights into disease pathogenesis and support the development of
more targeted treatments for inflammatory disorders.
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administration. In the duodenum at 1.5 hours after LPS
administration, mean villus height was reduced by 29% (Fig. 1B)
to 260.5±15.0 μm compared with villi from untreated mice
(365.9±6.6 μm) (P<0.01: ANOVA). The reduction in villus height
was still evident in treated versus non-treated mice through to 6
hours post-LPS (all P<0.05: ANOVA). A similar trend was also
observed in both the jejunum and ileum, but differences did not
reach statistical significance.
Villus shortening was associated with lower numbers of IECs
lining the duodenal villi, with a 21% reduction in mean cell number
observed at 1.5 hours post LPS administration compared with
controls (62.7±3.7 versus 78.5±1.8 IECs in untreated mice), reaching
significance at 3 hours, at which point a 40% decrease was observed
(47.0±4.7 IECs, P<0.05: Kruskal-Wallis) (Fig. 1C). This correlated
with large numbers of shed IECs within the intestinal lumen,
suggesting that cell shedding occurs contemporaneously with villus
shortening.
LPS significantly increased gut-to-circulation permeability by 
5 hours
In order to measure gut-to-circulation permeability, mice were
administered fluorescein-isothiocyanate-conjugated dextran (FD4)
by oral gavage, followed by 10 mg LPS/kg body weight. At 5 hours
post-LPS (5 hours FD4), there was a fivefold increase (P<0.05:
Kruskal-Wallis) in plasma fluorescence, at 76.3±21.7 fluorescent
units (Fig. 1D), compared with untreated mice (16.4±2.9 at 5 hours
FD4), suggesting that gut barrier dysfunction allows large molecules
to enter the bloodstream at around 5 hours post-LPS.
LPS caused activation of caspase-3 with concomitant apoptosis
and shedding of villus IECs, and relatively spared the crypts
To investigate the type of cell death responsible for IEC shedding
and loss from the villus, we performed immunohistochemistry
(IHC) for active caspase-3. Large numbers of villus IECs exhibited
positive immunolabeling as early as 1 hour, with almost universal
immunolabeling of shed cells seen within the small intestinal lumen
(Fig. 2A). Villus IECs were quantified by microscopy as ‘apoptotic’
or ‘shedding’ (as defined in Materials and Methods and summarized
in Fig.  2B) and expressed as a percentage of total villus IECs
counted.
Maximal active caspase-3 labeling of 12.5±1.7% villus IECs was
found in the duodenum 1.5 hours after LPS (Fig. 2C), representing
a 21-fold increase compared with untreated mice (0.6±0.2%,
P<0.05: Kruskal-Wallis). Comparable IEC apoptosis and cell
shedding were also observed at 1.5 hours after LPS treatment in
the jejunum and ileum (12.1±2.4% and 11.2±1.3%, respectively).
We therefore concluded that LPS caused dynamic villus IEC
apoptosis and shedding, and that this occurred relatively
uniformly throughout the small intestine. The almost universal
positive labeling of IECs undergoing shedding additionally
suggests that activation of the terminal pathway of apoptosis
occurs prior to shedding in this model, rather than being triggered
by detachment as occurs during the process of anoikis.
Interestingly, crypt IEC apoptosis as interpreted by active caspase-
3 IHC did not show a comparable magnitude of increase to that
observed in villi at 1.5 hours (Fig.  2D), although there was an
~threefold increase by 6 hours post-LPS (1.2±0.3% versus
Fig. 1. LPS at 10 mg/kg body weight
caused acute diarrhea, villus epithelial
cell loss, villus shortening and
increased gut permeability. (A)Small
intestine of an untreated control (white
arrow) and a WT mouse 1.5 hours after
LPS treatment exhibiting a fluid-filled
small intestine devoid of digesta (blue
arrow) with diarrheic feces at anus (blue
arrowhead). Caeca are indicated by white
arrowheads. H&E-stained sections of
duodenum (100×) show normal villi in an
untreated control and shortened,
blunted and clubbed villi with shed IECs
in the lumen at 1.5 hours post-LPS. Scale
bars: 200 μm. Villus tips (630×) are shown
in an untreated control, and shedding
IECs are seen at 1.5 hours post-LPS
(arrows). Scale bars: 25 μm. (B)Villus
heights for duodenum, jejunum and
ileum (n=6). (C)Hemivillus IEC counts
from base to apex for duodenum,
jejunum and ileum (n=6). (D)Plasma
fluorescence measured after 10 mg PE-
LPS/kg body weight and gavage of FD4.
n=6, one outlier excluded at 1.5 hours.
*P<0.05, **P<0.01. Comparisons by
ANOVA in A, and Kruskal-Wallis in B-D.
D
ise
as
e 
M
od
el
s &
 M
ec
ha
ni
sm
s  
    
   D
M
M
Disease Models & Mechanisms 1391
LPS-induced epithelial shedding RESEARCH ARTICLE
0.4±0.1% in untreated). Accordingly, crypt counts did not alter
significantly throughout the time course studied (Fig.  2E), in
contrast to villus IEC counts.
LPS-induced apoptosis and cell shedding increased towards the
villus tip
Administration of LPS (10 mg/kg body weight) increased the
number of apoptotic and/or shedding IECs with similar
distribution along the villus axis in the duodenum, jejunum and
ileum (Fig. 2C). Apoptosis was markedly increased in the apical
50% of the villus, particularly at 1.5 hours, with a sharp increase
in IEC shedding being observed at the villus tip, compared with
controls.
LPS caused maximal apoptosis and shedding at a threshold dose
We administered 0.125-20 mg PE-LPS/kg body weight to WT mice
and euthanized them after 1.5 hours to test whether LPS-induced
IEC apoptosis and shedding was dose dependent. LPS at 0.125
mg/kg caused a minimal (5%) reduction in villus height [348.1±17.1
μm versus 399.0±35.5 μm in vehicle-treated control mice (Fig. 3A)]
but with a tenfold observed increase in IEC apoptosis and cell
shedding at 6.0±1.7% (P<0.05: ANOVA) (Fig. 3B). LPS doses ≥0.25
mg/kg body weight caused ~30% reduction in villus height
compared with controls, and IEC apoptosis and cell shedding of
~12%. We concluded that LPS-induced small intestinal injury is
initiated by a threshold dose of ~0.125 mg/kg body weight. Villus
IECs therefore seem to be extremely sensitive to LPS-induced
Fig. 2. LPS caused activation of caspase-3 with concomitant apoptosis and shedding of villus IECs, and relatively spared the crypts. (A)Duodenal
sections labeled for active caspase-3 by IHC. Arrowhead indicates a positively labeled apoptotic IEC with unaltered morphology, and arrow indicates a positively
labeled IEC with shedding morphology. Scale bars: 200 μm (50×), 25 μm (630×). (B)Example of a duodenal villus 1.5 hours following administration of 10 mg PE-
LPS/kg body weight to a C57BL/6 female mouse. Individual cells were counted along the epithelial monolayer lining one side of a villus (delineated by red line)
from base to tip, and therefore referred to as a ‘hemivillus’. Cells were categorized as ‘normal’, ‘apoptotic’ or ‘shedding’. A total of 18-20 hemivilli were analyzed for
each intestinal segment for each individual animal. (C)Quantification of apoptotic and shedding IECs in the duodenum, jejunum and ileum (bar graphs), and cell
positional quantification of ‘apoptotic’ or ‘shedding’ IECs in the duodenum, jejunum and ileum along villus length (line graphs; 0% villus length represents the
villus base, 100% represents the villus tip). (D)Quantification of active-caspase-3-positive cells in villus versus crypt IECs. (E)Villus versus crypt IEC counts. n=6
female mice/group; *P<0.05, comparisons by ANOVA.
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apoptosis and cell shedding, whereas concomitant villus shortening
only occurs at higher dosages of LPS.
LPS purity did not significantly affect IEC apoptosis and shedding
To assess whether the LPS purification and/or extraction method
altered IEC apoptosis and shedding, we administered high-purity
ion-exchange chromatography extracted LPS (IE-LPS; 10 mg/kg
body weight) to WT mice for 1.5 hours. This preparation caused
similar villus shortening to 10 mg PE-LPS/kg body weight
(298.0±39.1 μm compared with 260.5±36.8 μm, respectively)
(Fig. 3C). IEC apoptosis and shedding post IE-LPS administration
were also significantly increased (10.8±2.8%) compared with
untreated WT, as observed for PE-LPS (12.5±1.7%) (Fig. 3D).
LPS-induced apoptosis and cell shedding was significantly decreased 
in Tlr4−/− mice and was due to TLR ligation peripheral to IECs
Because TLR4 is necessary for the innate immune system to
respond to LPS (Beutler et al., 2001), we investigated whether
Tlr4−/− mice would exhibit LPS-induced small intestinal injury, to
exclude the possibility of alternative mechanisms. IE-LPS (10
mg/kg body weight) caused negligible change in villus height in
Tlr4−/− mice (Fig. 3C) and negligible IEC apoptosis and shedding
compared with WT mice (Fig. 3D). However, it should be noted
that, when Tlr4−/− mice were administered 10 mg PE-LPS/kg body
weight, although this resulted in negligible change in villus height
compared with untreated Tlr4–/– mice (Fig.  3C), moderate IEC
apoptosis and shedding of 7.0±1.0% IECs was seen (Fig. 3D). To
exclude the possibility that IEC apoptosis and shedding was affected
by direct TLR ligation in IECs, we additionally tested the response
of Villin-Cre (Vil-Cre) Myd88−/− mice, which lack the TLR signaling
adapter molecule Myd88 in IECs, to systemic administration of 10
mg PE-LPS/kg body weight. These mice showed very comparable
amounts of apoptosis and shedding (14.1±1.1% IECs) to their WT
and heterozygous counterparts (Fig. 3E). Furthermore, we tested
the small intestinal response to LPS by alternative routes of
administration at 1.5 hours. We found that, although
Fig. 3. LPS caused a plateau in apoptosis and shedding at a threshold dose through TLR4 signaling peripheral to epithelial cells. (A)Heights of duodenal
villi 1.5 hours after PE-LPS administration at the indicated doses and (B) quantification of percentage apoptotic and shedding IECs by assessment of duodenal
sections labeled for active caspase-3 by IHC. n=6 female mice/group for PBS, 0.125 mg/kg and 10 mg/kg, and n=4 female mice for all other groups. (C)Villus
heights in WT or Tlr4−/− mice 1.5 hours after PE-LPS or IE-LPS treatment at 10 mg/kg, and (D) quantification of IEC apoptosis and shedding in IHC-labeled
duodenal sections (n=6). (E)Quantification of apoptotic and shedding IECs in WT (n=6), Vil-Cre Myd88−/− (n=3) and Vil-Cre Myd88+/− (n=3) mice by assessment of
duodenal sections labeled for active caspase-3 by IHC. (F)Small intestinal villi from WT female mice 1.5 hours post-PE-LPS by subcutaneous (s.c.) or intravenous
(i.v.) routes exhibited villus IEC apoptosis and shedding, but not when LPS was instilled intraluminally [active caspase-3 IHC, duodenum shown for s.c. and i.v. LPS
(n=3 per group), ileum shown for intraluminal administration instilled with 1 mg/ml LPS (n=4 per group)]. Scale bars: 25 μm. *P<0.05, **P<0.01. Comparisons by
ANOVA in A-C, and by Kruskal-Wallis and pairwise comparison of LPS-treated mice only in D.D
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intraperitoneal, intravenous or subcutaneous LPS administration
caused IEC apoptosis and shedding, when LPS was delivered
directly into the lumen of a ligated segment of small intestine in
terminally anesthetized WT mice, this did not initiate apoptosis
and shedding (Fig. 3F).
These results suggest that LPS-induced small intestinal injury is
dependent on TLR4 signaling peripheral to IECs and that additional
bacterial components in PE-LPS cause IEC shedding via TLR4-
independent mechanisms.
Nfĸb1−/− mice were more sensitive, and Nfĸb2−/− mice more
resistant, to LPS-induced intestinal injury
NFκB is a major transcriptional regulator downstream of TLR4.
We therefore administered PE-LPS to Nfĸb1−/− and Nfĸb2−/− mice,
to establish whether either of these subunits, integral to the
canonical and non-canonical NFĸB signaling pathways,
respectively, is necessary for LPS-induced small intestinal injury.
After administration of 10 mg LPS/kg body weight, similar villus
shortening was seen in Nfĸb1−/− and WT mice (Fig. 4A). This
genotype also showed similar IEC apoptosis and shedding to WT
mice (Fig. 4B). In contrast, Nfĸb2−/− mice showed a significantly
attenuated 11% villus height reduction in treated versus untreated,
compared with 32% in treated versus untreated WT (P<0.05:
Kruskal-Wallis) (Fig. 4A), and reduced IEC apoptosis and shedding
compared with WT mice (Fig. 4B). Interestingly, when 0.125 mg
LPS/kg body weight was administered, Nfĸb1−/− mice showed
greater villus shortening (supplementary material Fig. S2) of 27%
in treated versus untreated (P<0.05: Kruskal-Wallis) compared with
5% shortening in treated versus untreated WT mice (Fig. 4A), and
significantly greater IEC apoptosis and shedding at 12.9±1.7% IECs
(P<0.05: Kruskal-Wallis) (Fig.  4C) compared with WT mice
(5.5±1.3%). IEC apoptosis and shedding in Nfĸb2−/− mice
administered 0.125 mg LPS/kg body weight were negligible
(0.8±0.2% IECs; P<0.05: Kruskal-Wallis) compared with WT mice.
Together, these results suggest that LPS-induced intestinal injury
is dependent on NFκB2, whereas NFκB1 might be necessary to
suppress IEC apoptosis and shedding.
LPS induced a significant increase in small intestinal Tnf mRNA
Because activation of caspase-3 does not categorically confirm that
cell death has occurred by apoptosis, we performed an array analysis
of 89 genes associated with various cell death pathways in PE-LPS-
treated compared with untreated WT animals. We found that LPS
predominantly altered expression of genes associated with
apoptosis, rather than those associated with autophagy or necrosis
(Fig. 5A). Tnf and Cd40 showed marked upregulation, and we
therefore analyzed these two proapoptotic genes by quantitative
PCR (qPCR) using triplicate samples from individual animals
(Fig. 5B). This showed a mean normalized gene expression ratio
of +32.0 for Tnf mRNA (P<0.05: randomization test). qPCR also
showed a non-significant increase of +2.1 for Cd40. These data, in
conjunction with histopathological findings and activation of
caspase-3, suggest that apoptosis is the predominant form of cell
death occurring in LPS-induced small intestinal injury.
TNF caused small intestinal injury equivalent to LPS
Because TNF is a key mediator of endotoxic shock, and was
markedly upregulated at the mRNA level in our array, we tested
whether TNF would cause comparable enteric injury to LPS. At
1.5 hours, TNF (0.33 mg/kg body weight; i.p.) caused equivalent
duodenal villus shortening (Fig. 6A) to that seen with 10 mg PE-
LPS/kg body weight (268.4±20.9 μm and 260.5±15.0 μm,
respectively). Although less IEC apoptosis and shedding were
observed with TNF (7.0±1.0% IECs) compared with 10 mg PE-
LPS/kg body weight (12.5±1.7% IECs) (Fig. 6B), this reflects a faster
small intestinal response to exogenously administered TNF
(supplementary material Fig. S3) than caused by LPS.
These data, together with significant induction of intestinal Tnf
mRNA, suggest that TNF is central in the pathogenesis of LPS-
induced small intestinal injury.
Fig. 4. Nfĸb1−/− mice were more sensitive, and Nfĸb2−/− mice more
resistant, to LPS-induced small intestinal injury. (A)Villus heights of
duodenal villi 1.5 hours after 0.125 mg/kg or 10 mg/kg PE-LPS in WT, Nfκb1−/−
and Nfκb2−/− mice (comparisons between genotypes within same dosage
groups only). (B,C)Quantification of apoptotic and shedding IECs in duodenal
sections labeled for active caspase-3 in WT, Nfĸb1−/− and Nfĸb2−/− mice 1.5
hours after 10 mg/kg PE-LPS (B) and after 0.125 mg/kg PE-LPS (C). n=12-14
(male and female equally represented); *P<0.05, comparisons by Kruskal-
Wallis.
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Tnfr1−/− mice were completely resistant to LPS-induced apoptosis
and cell shedding
We decided to further examine the role of TNF by testing whether
the TNF receptors TNFR1 (p55) or TNFR2 (p75) were required to
cause LPS-induced gut injury. When Tnfr1−/− mice were
administered 10 mg PE-LPS/kg body weight for 1.5 hours, there
was no villus shortening (Fig.  6C) and significantly less IEC
apoptosis and shedding were seen relative to WT animals
(0.1±0.1%, P<0.05: Kruskal-Wallis; Fig. 6D). By contrast, the same
dose administered to Tnfr2−/− mice caused 68% of the response
caused in WT, at 8.5±1.0% IEC apoptosis and shedding, although
this did not cause a significant change in villus height (Fig. 6C).
These findings suggest that TNFR1 signaling is required to drive
LPS-induced IEC apoptosis and shedding, with potential
enhancement by TNFR2.
Nfĸb1−/− mice were highly sensitive, and Nfĸb2−/− resistant, to TNF-
induced small intestinal injury
NFκB is also a major exponent of downstream TNFR signaling.
We therefore administered TNF to Nfĸb1−/− and Nfĸb2−/− mice.
Nfĸb1−/− mice were highly sensitive to TNF (supplementary
material Fig.  S2) and exhibited a significant reduction in villus
height compared with TNF-treated WT mice (villus heights of
160.1±7.3 and 268.4±20.9 μm, respectively; P<0.05: ANOVA;
Fig. 6E). This correlated with increased IEC apoptosis and shedding
in Nfĸb1−/− versus WT mice (9.9±0.7 and 7.0±1.0% IECs,
respectively; P<0.05: ANOVA). Conversely, Nfĸb2−/− mice were
resistant to the TNF-induced reduction in villus height (340.1±15.1
μm) and IEC apoptosis and shedding (2.5±0.7%) compared with
similarly treated WT animals (both P<0.05; Fig. 6F).
These data suggest that IEC apoptosis and shedding in response
to LPS or TNF are regulated by a common NFκB signaling pathway,
being suppressed by NFκB1 but promoted by NFκB2.
DISCUSSION
We present a detailed study of acute LPS-induced murine gut injury.
Systemic LPS administration caused rapid IEC apoptosis and
shedding in the murine small intestinal villus, and this resulted in
shortening of the villus, fluid effusion into the small intestinal lumen
and diarrhea.
We have characterized the dose response and kinetics of this
highly dynamic phenomenon and demonstrate that it occurs within
a tightly defined time period. All regions of the small intestine
responded in a similar manner to LPS and in all cases apoptosis
and cell shedding occurred in the apical 50% of the villus rather
than exclusively at the tip. Using knockout mouse models, we
confirmed that TLR4 signaling peripheral to the IEC was required,
and that TNFR1-mediated signaling was essential for these events,
with an NFκB2-dominant response favoring apoptosis.
Although there is an abundance of literature describing small
intestinal crypt apoptosis several hours after the induction of
endotoxic or septic shock (Cinel et al., 2002; Coopersmith et al., 2003;
Guma et al., 2011), we present novel observations that the villus IECs
respond much more rapidly than crypt IECs, and exhibit exquisite
susceptibility to apoptosis and cell shedding in the earliest phases
following LPS administration. The only other study to date that has
examined small intestinal villus epithelial shedding in response to
LPS studied this response from 5.5 hours post-LPS-administration
by in vivo confocal microscopy, correlating gap formation with gut
barrier dysfunction (Lai et al., 2013). This highlights the necessity of
a detailed study of the kinetics of this response because, in our model,
we found that the number of shedding events was profoundly reduced
by 4 hours after LPS administration and the maximum response was
observed as early as 1.5 hours. We found that, although multiple
organ failure in the context of endotoxic shock has been extensively
investigated, most commonly by biochemical parameters, obvious
organ injury in terms of apoptosis was confined to the small intestine
at the early time points examined herein. The reasons underlying
this selective early injury to the villus IECs of the murine small
intestine are not entirely clear. However, this phenomenon has been
attributed to the greater sensitivity of the intestinal epithelium to
mitochondrial damage than epithelia found in other commonly
injured organ systems such as the lung. Interestingly, in the feline
septic shock model in which this was demonstrated, other obvious
hemodynamic derangements to which this effect might have been
attributed, such as hypotension, intestinal hypoperfusion and
hypoxia, were shown not to be responsible (Julian et al., 2011).
Additionally, in our own studies, this small intestinal injury occurred
by 1.5 hours not only when LPS was administered intraperitoneally,
but also when given intravenously or subcutaneously, suggesting that
this injury is not due to a localized phenomenon.
Clinically, we found that the onset of diarrhea correlated
temporally with IEC apoptosis and shedding. This suggests that
the shedding of IECs permits the net movement of fluid from the
plasma into the intestinal lumen. This might be directly due to the
rapid and uncoordinated shedding of IECs, potentially in
Fig. 5. LPS induced a significant increase in small intestinal Tnf mRNA.
(A)qPCR array data for selected genes that exhibited a ≥twofold expression
ratio out of 89 cell-death-pathway-associated genes assessed in pooled
epithelial enriched extracts. (B)Mean gene expression ratio of PE-LPS-treated
(10 mg/kg, 1.5 hours) versus untreated WT female mice for Cd40 and Tnf. n=4,
*P<0.05: randomization test.
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conjunction with increased vascular permeability, which causes
disruption of both tight junctions and the paracellular space. Our
own studies have previously shown that barrier loss in the intestine
occurs at sites of excessive cell shedding (Kiesslich et al., 2012), and
that the direction of fluid movement through epithelial defects is
highly dependent on the osmotic and hydrostatic gradients across
the epithelium. The concept of acute fluid exudation into the
intestinal lumen after the administration of inflammatory stimuli
has also been recognized in other studies utilizing LPS or TNF
(Gadjeva et al., 2007; Kiesslich et al., 2012). It was not until 5 hours
after LPS administration, however, that we found movement of
larger molecules (FD4) from the lumen to the plasma. This is in
agreement with findings from in vivo confocal microscopy that,
from 5.5 hours after LPS administration, FD4 entered cell-free gaps
and paracellular spaces (Lai et al., 2013).
In our model, a high-purity preparation of LPS caused villus IEC
apoptosis and shedding through a TLR4-dependent mechanism,
but PE-LPS of lower purity was capable of inducing a moderate
response via TLR4-independent mechanisms, most likely due to
ligation of alternative TLRs by residual impurities such as bacterial
RNA. In support of other PAMPs causing this type of response,
another recent study has demonstrated that the apoptosis in the
intestinal villus by the viral PAMP, double-stranded RNA, occurred
via TLR3 (McAllister et al., 2013). TLR3, in contrast to other TLRs,
signals exclusively via the TRIF pathway rather than the Myd88
pathway (Kawai and Akira, 2011). As such, this agonist represents
an unusual type of inflammatory response. It caused apoptosis by
a TRIF-dependent and TNF-independent mechanism, which
peaked at 2 hours post-administration, possibly reflecting delayed
activation of the TRIF pathway compared with the Myd88 pathway
(Pålsson-McDermott and O’Neill, 2004).
Most previous studies have found only low-level expression of
TLR4 in IECs (Abreu, 2010). Therefore, rather than occurring in
IECs themselves, initial recognition of systemically delivered LPS
likely occurs via TLR4 ligation in monocytes and macrophages,
which in turn rapidly secrete cytokines, including TNF (Beutler et
al., 1985). To confirm this mechanism in our model, we
administered LPS by i.p. injection to Vil-Cre Myd88−/− mice that
specifically lacked intestinal TLR signal transduction (Fig. 3E). They
showed comparable IEC apoptosis and shedding to their
Fig. 6. LPS induced small intestinal IEC apoptosis and shedding
via TNF and TNFR1, and was regulated by NFκB. Villus heights and
IEC apoptosis and shedding 1.5 hours after 10 mg/kg PE-LPS or 0.33
mg/kg TNF in WT mice (A,B), after 10 mg/kg PE-LPS in WT, Tnfr1−/−
and Tnfr2−/− mice (C,D), and after TNF administration in WT, Nfκb1−/−
and Nfĸb2−/− mice (E,F). *P<0.05; n=4-6 mice per group; comparisons
by ANOVA, except in D (Kruskal-Wallis).
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heterozygous counterparts and WT mice of the same strain,
demonstrating that peripheral TLR signaling is required for LPS-
induced small intestinal injury.
LPS signaling is additionally dependent on delivery of LPS to the
cell membrane in a bioactive form by lipopolysaccharide binding
protein (LBP) and the adapter molecules CD14 (Wright et al., 1990)
and MD-2 (Shimazu et al., 1999). TLR4 signaling might also therefore
be fundamentally different in IECs, preventing what would be
constant stimulation by the luminal Gram-negative bacterial
population. Indeed, in cell culture of m-ICcl2 murine IECs, TLR4
was found to reside within the Golgi apparatus, rather than at the cell
membrane (Hornef et al., 2002). In our studies, we found that LPS (1
mg/ml) instilled directly into the lumen of a ligated segment of small
intestine for 1.5 hours did not cause apoptosis and cell shedding.
Similarly, double-stranded RNA has failed to elicit apoptosis and
shedding when administered orally (McAllister et al., 2013).
The rapid increase in plasma TNF concentration after LPS
administration has been previously characterized (Copeland et al.,
2005). In the current study, we also demonstrated a large fold change
in Tnf mRNA abundance in small intestinal epithelial enriched
extracts 1.5 hours after LPS administration. The significance of TNF
as the crucial mediator in our model was further demonstrated by
the fact that TNF administration caused very comparable IEC
apoptosis and shedding as did LPS, consistent with previous results
(Garside et al., 1993; Piguet et al., 1998). In the intestinal epithelium,
and in intestinal cell lines, TNFR1 is expressed to a greater extent
than TNFR2 (Lau et al., 2011; Mizoguchi et al., 2002), although the
latter can be induced by inflammatory cytokines (Mizoguchi et al.,
2002). TNFR1 has well-defined proapoptotic effects (Locksley et al.,
2001) and, in our model, was essential for LPS-induced IEC apoptosis
and shedding. This suggests that direct TNFR1 ligation occurs at
the level of the IEC, although interactions in intermediary cell types,
such as endothelial or myofibroblast cells, cannot be excluded. The
role of TNFR2 has been less well characterized and interestingly the
intestinal epithelial response to LPS was moderate in Tnfr2−/− mice,
suggesting that this receptor does participate in LPS-induced IEC
apoptosis, possibly by enhancing TNFR1 signals through degradation
of TRAF2, resulting in termination of NFκB signaling (Rodríguez et
al., 2011).
Mice deficient in NFκB1, an individual NFκB family member that
signals via the canonical activation pathway, developed more IEC
apoptosis and shedding in response to TNF than did WT mice. This
is not surprising because TNFR1, as well as initiating apoptosis, also
induces the expression of anti-apoptotic genes via NFκB (Wang et
al., 1998). However, an interesting finding to emerge from our study
was that mice deficient in NFκB2, an NFκB family member that
signals via the alternative activation pathway, were more resistant to
villus IEC apoptosis and shedding in response to TNF, compared
with WT mice. This suggests that alternative NFκB2 pathway
activation contributes to cell shedding and apoptosis. A possible
mechanism to account for this effect could be due to the NFκB2
precursor acting as an inhibitor of NFκB activity (Basak et al., 2007;
Fukushima et al., 2012). Absence of NFκB2 might therefore result
in an extended expression of p65 (RelA)-induced anti-apoptotic genes
(summarized in Fig. 7). The importance of p65 nuclear translocation
in IECs that do not undergo shedding has been previously
demonstrated in Cryptosporidium parvum infection (Foster et al.,
2012). Alternatively, NFκB2-containing dimers might directly
terminate the transcription of anti-apoptotic genes or induce the
expression of proapoptotic genes.
In conclusion, we provide a detailed description of the early
events and mechanisms that are responsible for acute, LPS-induced
small intestinal injury. LPS therefore represents a robust, rapid and
consistent stimulus for inducing pathological small intestinal
epithelial cell apoptosis and shedding. Further study of this
phenomenon could be highly relevant to our understanding of the
initial pathogenesis of acute small intestinal disease states and
diarrheal illnesses, and the intestinal manifestations of acute
systemic disease states such as septic and endotoxic shock.
Additionally, the very acute small intestinal lesions documented in
this study might also contribute to development of chronic
inflammation, such as is observed in IBD. Indeed, defective small
intestinal permeability such as that which might occur in IEC
shedding has been shown to contribute to the development of
chronic colitis (Arrieta et al., 2009), meaning that this model might
have relevance in CD or UC development. Ultimately, this could
lead to the development of novel therapeutic strategies to
ameliorate pathological villus epithelial cell apoptosis and shedding,
and gut barrier dysfunction.
MATERIALS AND METHODS
Animals
Wild-type (WT) C57BL/6 mice supplied by Charles River (Margate,
UK), and transgenic strains on a C57BL/6 background, including
Nfĸb1−/− and Nfĸb2−/− mice (Caamaño et al., 1998; Sha et al., 1995)
Fig. 7. Diagram summarizing the putative mechanism by which LPS
induces apoptosis in IECs. Systemically delivered LPS is first recognized
predominantly by resident TLR4-expressing mononuclear cells
(monocytes/macrophages/dendritic cells), which produce TNF. TNF is released
into the systemic circulation and binds with TNFR1 on IECs, triggering
apoptosis and shedding if NFκB2 signaling dominates, or cell survival if NFκB1
signaling dominates.
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and Tlr4−/− mice (Hoshino et al., 1999) (generated by Shizuo Akira
and supplied by Mark Taylor) were maintained at the University
of Liverpool. Tnfr1−/− and Tnfr2−/− mice (Peschon et al., 1998) were
maintained at the Saban Research Institute at Children’s Hospital
Los Angeles. Vil-Cre Myd88−/− mice were maintained at the
Disease Modelling Unit, University of East Anglia. All procedures
were performed on adult mice (minimum age 9 weeks) under
appropriate UK Home Office licenses or with approval and
monitoring by the Children’s Hospital Los Angeles Institutional
Animal Care and Use Committee.
Generation of Vil-Cre Myd88−/− mice
Myd88fl/fl, which express a truncated mutant Myd88 protein
following removal of the floxed region, were bred with Vil-Cre mice,
which conditionally express Cre recombinase under control of the
villin promoter. Offspring were genotyped for the presence of WT
Myd88, mutated Myd88 and Cre alleles. Mice were on a C57BL/6
genetic background.
Lipopolysaccharide
LPS from Escherichia coli O111:B4 purified by phenol-extraction (PE-
LPS) or ion-exchange chromatography (IE-LPS) (Sigma-Aldrich,
Gillingham, UK) was diluted in sterile phosphate-buffered saline
(PBS) and administered to mice by intraperitoneal (i.p.) injection.
TNF
Murine recombinant TNF (Peprotech Ltd, London, UK) was
diluted in sterile water and administered by i.p. injection to mice
at 0.33 mg/kg body weight.
Tissue processing
Following euthanasia, the intestinal tract was dissected en bloc. The
intestinal lumina were flushed with PBS and immediately fixed in
10% neutral buffered formalin with selected organ samples. After
24 hours fixation, tissue was routinely processed and embedded in
paraffin wax. Tissue sections (3-5 μm thickness) were prepared and
stained either with H&E or used for immunohistochemistry (IHC).
Immunohistochemistry for apoptotic IECs
Tissue sections were treated with 1% hydrogen peroxide in
methanol to block endogenous peroxidases, followed by heat-
induced antigen retrieval in 0.01 M citrate acid buffer (pH 6) 
and incubation with a rabbit polyclonal anti-active-caspase-3
antibody (AF835: R&D Systems, Abingdon, UK). Peroxidase-
labeled anti-rabbit EnVision™ (Dako, Cambridge, UK) and 3,3-
diaminobenzidine were used for visualization.
Quantification of active-caspase-3-positive cells
For quantification of apoptotic and shedding IECs, individual
epithelial cells were counted from the base of the villus (above crypt
level) to the mid-point of the villus tip in 18-20 well-orientated
hemivilli at 400× magnification (delineated by red line in Fig. 2B).
IECs were categorized according to the following criteria:
• ‘normal’ if there was no or weak diffuse non-specific brown
staining and cells had a basally located basophilic nucleus;
• ‘apoptotic’ if there was defined positive staining that was
confined to cytoplasmic or nuclear borders when compared with
any background staining of neighboring IECs;
• ‘shedding’ if there was defined positive staining that was
confined to cytoplasmic or nuclear borders and in addition there
was apical elevation of the cytoplasmic membrane, and/or an
apically positioned nucleus.
Crypt IECs were counted from the crypt base to the crypt-villus
junction in 19-20 well-orientated duodenal hemicrypts per mouse.
Crypt IECs were simply categorized as ‘normal’ or ‘apoptotic’
because no discernible evidence of shedding was observed within
crypts.
Cell positional data
To allow comparison of cell positional data, villi were adjusted to
a fixed length of 100 cells by using Wincrypts© software (Cancer
Research Campaign 1999). Data are then represented as percentage
of villus length, 0% therefore representing the villus base and 100%
representing the villus tip.
Measurement of villus height
ImageJ (Schneider et al., 2012) was used to assess images captured
by a Leica DMLA microscope, by setting the scale with a
hemocytometer at 100× magnification. All images were captured
at 100× magnification, and villi were measured by using the
segmented line tool. Each segmented line was placed to originate
at the base of the villus, above the level of adjoining crypts, and a
segmented line extended to the villus tip, following any curvature
of the villus. The mean of these segmented line lengths for ten well-
orientated villi was calculated for each animal, and a mean value
was then calculated for each group.
Gut permeability assessment
Fluorescein-isothiocyanate-conjugated dextran (FD4: Sigma-
Aldrich, Gillingham, UK) was diluted to 22 mg/ml in PBS and
administered at 20 ml/kg body weight by oral gavage ± i.p. injection
of LPS. Plasma fluorescence was measured by a TECAN Infinite®
F200 plate reader (excitation 485 nm, emission 535 nm) from blood
collected post-mortem at 5 hours after gavage in order to allow
FD4 to be distributed throughout the intestinal tract. Mice were
euthanized via a rising CO2 concentration and blood taken by
cardiac puncture. To assess the effect of LPS on permeability, it
was administered at set time points prior to the end of the
experiment, i.e. at 1.5 hours, 3 hours and at the same time as FD4
for the 5-hour time point. Plasma was separated from heparinized
whole blood by centrifugation at 5000  rpm for 2  minutes in a
minicentrifuge.
Real-time PCR
Small intestinal extracts were isolated with chelation buffer
solution as previously described (Flint et al., 1991), and RNA was
isolated with a High Pure RNA Tissue Kit (Roche, Burgess Hill,
UK). Reverse-transcription was performed with an RT2 reverse-
transcription kit (SABiosciences, Crawley, UK). An 89 gene 
Cell-Death Pathway Finder array (SABiosciences) was performed
on a Roche LightCycler®480 followed by validation with 
replicate samples using TaqMan® gene expression assays for 
β-actin (Mm01205647_g1), TNF (Mm00443260_g1) and 
CD40 (Mm00441891_m1; Life Technologies, Paisley, UK). 
Cycling conditions were performed as per the manufacturer’s
instructions.
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Data analysis
Data represent mean ± s.e.m. Comparisons were made between
treatment groups and controls using SigmaPlot 12© (Systat
Software, London, UK). Normally distributed data were assessed
by ANOVA with Holm-Sidak post-hoc test, and non-parametric
data were analyzed by ANOVA on ranks (Kruskal-Wallis) with
Dunn’s post-hoc test. P<0.05 was considered significant. REST©
software was used for comparison of qPCR data from
individualized samples by randomization test as previously
described (Pfaffl et al., 2002). n numbers indicate the total
number of mice studied.
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Supplementary Figure 3: TNF caused more rapid small intestinal apoptosis and 
shedding than LPS. TNF (0.33mg/g) caused very similar amounts of apoptosis and 
IEC shedding at 1h to that caused by 10mg/kg PE-LPS at 1.5h.  By 1.5h, maximum 
apoptosis and shedding had subsided in TNF treated animals (n=4-6 C57BL/6 female 
mice/group).  
  
